Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 50/Bag
Request Sample
Manufacturer/Factory

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (11)
  • Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
  • Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
  • Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
  • Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
  • Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
  • Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
Find Similar Products

Basic Info.

Model NO.
Frazer-Glatiramer Acetate
Suitable for
Elderly, Children, Adult
State
White Powder
Purity
>99%
Grade
Medicine Grade
Appearance
White Powder
CAS No
147245-92-9
Shelf Life
2 Years
Test Method
HPLC
MOQ
1kg
Storage
Store Cool Dry Place
Resource
Natural
Mf
C25h45n5o13
Transport Package
Ziplock Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
2000kg/Month

Product Description

Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9

Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9
 
Boiling Point 385.2ºC at 760mmHg
Molecular Formula C25H45N5O13
Molecular Weight 623.65000
Flash Point 186.7ºC
Exact Mass 623.30100
PSA 374.13000
LogP 2.14760
Vapour Pressure 1.27E-06mmHg at 25°C


What is Glatiramer acetate?

Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone - as marketed by Teva Pharmaceuticals) is animmunomodulator drug currently used to treat multiple sclerosis. Glatiramer acetate is a random polymer of four amino acids found inmyelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system. 
Although the clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs, glatiramer acetate is approved for treatment after single episodes. Glatiramer acetate is also used to treat relapsing-remitting multiple sclerosis. Glatiramer acetate is administered by subcutaneous injection.


Function and Application of Glatiramer acetate

Glatiramer acetate is approved by the Food and Drug Administration (FDA) for reducing the frequency of
relapses, but not for reducing the progression of disability. Observational studies, but not randomized
controlled trials, suggest that Glatiramer acetate may reduce progression of disability.

Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9

Product Name CAS No. Product Name CAS No.
Lufenuron 103055-07-8 Toltrazuril 69004-03-1
Nitenpyram 120738-89-8 Praziquantel/Biltricide 55268-74-1
Fenbendazole 43210-67-9 Tetramisole Hcl 5086-74-8
Levamisole 14769-73-4 Ponazuril 9004-4-2
Diclazuril 101831-37-2 Florfenicol 73231-34-2
Ivermectin 70288-86-7 Enrofloxacin Hcl 112732-17-9
Albendazole 54965-21-8 Mebendazole 31431-39-7
Pharmaceutical Intermediates Glatiramer Acetate CAS 147245-92-9

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier